Second Generation Dengue Vaccine Produces Durable T-Cell Protection

In COVID-19, Latest News by Precision Vaccinations

Every virologist says creating robust cellular responses is essential for protecting people against infectious diseases. While vaccine immunogenicity evaluations often focus predominantly on antibody responses, generating cellular immunity is crucial for long-term protection.
To appreciate the benefits of any vaccination, measuring T-cell responses is essential, especially for disease outbreaks such as dengue fever, which has four sub-viruses (DENV-1, -2, -3, and -4).

Read More